Vident Advisory’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,748
Closed -$239K 1698
2025
Q1
$239K Buy
3,748
+815
+28% +$52K ﹤0.01% 1361
2024
Q4
$357K Buy
+2,933
New +$357K 0.01% 1104
2024
Q3
Sell
-2,100
Closed -$332K 1542
2024
Q2
$332K Sell
2,100
-19
-0.9% -$3K 0.01% 1088
2024
Q1
$274K Sell
2,119
-180
-8% -$23.3K 0.01% 1082
2023
Q4
$222K Buy
2,299
+265
+13% +$25.6K 0.01% 1167
2023
Q3
$247K Buy
+2,034
New +$247K 0.01% 1017